Blonder Tongue Laboratories Stock Forecast, Price & News

Blonder Tongue Laboratories (NYSEAMERICAN:BDR) Frequently Asked Questions

Are investors shorting Blonder Tongue Laboratories?

Blonder Tongue Laboratories saw a increase in short interest in the month of October. As of October 29th, there was short interest totaling 87,600 shares, an increase of 20.0% from the October 14th total of 73,000 shares. Based on an average daily volume of 338,100 shares, the days-to-cover ratio is presently 0.3 days. Currently, 1.3% of the company's stock are short sold.
View Blonder Tongue Laboratories' Short Interest.

How were Blonder Tongue Laboratories' earnings last quarter?

Blonder Tongue Laboratories, Inc. (NYSEAMERICAN:BDR) issued its quarterly earnings results on Friday, May, 15th. The technology company reported ($0.21) EPS for the quarter. The technology company had revenue of $4.05 million for the quarter. Blonder Tongue Laboratories had a negative trailing twelve-month return on equity of 56.15% and a negative net margin of 8.71%.
View Blonder Tongue Laboratories' earnings history.

Who are Blonder Tongue Laboratories' key executives?

Blonder Tongue Laboratories' management team includes the following people:

• Edward R. Grauch, President & Chief Executive Officer
• Allen Horvath, Senior Vice President-Operations
• Eric S. Skolnik, CFO, Secretary, Treasurer & Senior Vice President
• Ronald V. Alterio, Chief Technology Officer & Senior VP-Engineering
• Robert J. Pallé, Director & Managing Director-Strategic Accounts

Who are some of Blonder Tongue Laboratories' key competitors?

Some companies that are related to Blonder Tongue Laboratories include BK Technologies (BKTI), SeaChange International (SEAC), Global Technologies (GTLL), Sonic Foundry (SOFO), Airspan Networks (AIRO), CareView Communications (CRVW), Superconductor Technologies (SCON), Brewbilt Brewing (SIML), GTX (GTXO), Northstar Electronics (NEIK), BrewBilt Brewing (SIMLD), BrewBilt Brewing (BRBL), COMARCO (CMRO), AfterMaster (AFTM) and Proxim Wireless (PRXM).
View all of BDR's competitors.

What other stocks do shareholders of Blonder Tongue Laboratories own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Blonder Tongue Laboratories investors own include VBI Vaccines (VBIV), Vaxart (VXRT), Co-Diagnostics (CODX), Aduro Biotech (ADRO), iBio (IBIO), Aethlon Medical (AEMD), (ALT), Amarin (AMRN), Actinium Pharmaceuticals (ATNM) and Biocept (BIOC).

What is Blonder Tongue Laboratories' stock symbol?

Blonder Tongue Laboratories trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "BDR."

How do I buy shares of Blonder Tongue Laboratories?

Shares of BDR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Blonder Tongue Laboratories' stock price today?

One share of BDR stock can currently be purchased for approximately $1.04.

How much money does Blonder Tongue Laboratories make?

Blonder Tongue Laboratories has a market capitalization of $12.89 million and generates $16.38 million in revenue each year. The technology company earns $-7.47 million in net income (profit) each year or ($0.18) on an earnings per share basis.

How many employees does Blonder Tongue Laboratories have?

Blonder Tongue Laboratories employs 85 workers across the globe.

What is Blonder Tongue Laboratories' official website?

The official website for Blonder Tongue Laboratories is www.blondertongue.com.

Where are Blonder Tongue Laboratories' headquarters?

Blonder Tongue Laboratories is headquartered at 1 Jake Brown Rd PO Box 1000, OLD BRIDGE, NJ 08857-1000, United States.

How can I contact Blonder Tongue Laboratories?

Blonder Tongue Laboratories' mailing address is 1 Jake Brown Rd PO Box 1000, OLD BRIDGE, NJ 08857-1000, United States. The technology company can be reached via phone at (732) 679-4000, via email at [email protected], or via fax at 732-679-4353.